Related references
Note: Only part of the references are listed.ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications
Peter Valent
PATHOBIOLOGY (2019)
Consequences of mutant TET2 on clonality and subclonal hierarchy
Cassandra M. Hirsch et al.
LEUKEMIA (2018)
Molecular Minimal Residual Disease in Acute Myeloid Leukemia
M. Jongen-Lavrencic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
Sergio Ferreira Cristina et al.
SEMINARS IN HEMATOLOGY (2018)
Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
Hyun-Young Kim et al.
ANNALS OF LABORATORY MEDICINE (2018)
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
Gregory W. Roloff et al.
BLOOD ADVANCES (2018)
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up
Alicia Senin et al.
ANNALS OF HEMATOLOGY (2018)
Emerging treatments for classical myeloproliferative neoplasms
Alessandro M. Vannucchi et al.
BLOOD (2017)
Subtype-specific patterns of molecular mutations in acute myeloid leukemia
D. Rose et al.
LEUKEMIA (2017)
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
Lars Bullinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Koichi Takahashi et al.
LANCET ONCOLOGY (2017)
Genomic determinants of chronic myelomonocytic leukemia
B. J. Patel et al.
LEUKEMIA (2017)
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
E. Hadzijusufovic et al.
LEUKEMIA (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)
Brigitte Schlegelberger et al.
SEMINARS IN HEMATOLOGY (2017)
Familial CEBPA-mutated acute myeloid leukemia
Kiran Tawana et al.
SEMINARS IN HEMATOLOGY (2017)
ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS
David A. Sallman et al.
BLOOD CANCER JOURNAL (2017)
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Peter Valent et al.
ONCOTARGET (2017)
Evolution of Premalignant Disease
Kit Curtius et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Familial MPN Predisposition
Tsewang Tashi et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal
Peter Valent et al.
EBIOMEDICINE (2017)
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling et al.
NATURE REVIEWS CANCER (2017)
Midostaurin: a magic bullet that blocks mast cell expansion and activation
P. Valent et al.
ANNALS OF ONCOLOGY (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
RUNX1 Mutations in Inherited and Sporadic Leukemia
Dana C. Bellissimo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
Terrence N. Wong et al.
BLOOD (2016)
Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation
Jie Peng et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Time-dependent changes in mortality and transformation risk in MDS
Michael Pfeilstoecker et al.
BLOOD (2016)
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
David A. Hinds et al.
BLOOD (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera
Sabit Delic et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis
Yun Lin et al.
HEMATOLOGY (2016)
Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms
T. Mori et al.
LEUKEMIA (2016)
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
Laura Palomo et al.
ONCOTARGET (2016)
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Hengning Ke et al.
CELL AND BIOSCIENCE (2016)
Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression
Catherine A. Cargo et al.
BLOOD (2015)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells
Elvira Pelosi et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia
Stephen M. Sykes et al.
EXPERIMENTAL HEMATOLOGY (2015)
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia
Manja Meggendorfer et al.
HAEMATOLOGICA (2015)
Aging, clonal hematopoiesis and preleukemia: not just bad luck?
Liran I. Shlush et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
Axel Schulenburg et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M. Jawhar et al.
LEUKEMIA (2015)
Effect of Mutation Order on Myeloproliferative Neoplasms
Christina A. Ortmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia
Manja Meggendorfer et al.
HAEMATOLOGICA (2015)
The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)
Luca Malcovati et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations
Sabine Jeromin et al.
HAEMATOLOGICA (2015)
STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia
Wolfgang Warsch et al.
Oncotarget (2015)
BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS
Liping Zhang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Cancer: Evolution Within a Lifetime
Marco Gerlinger et al.
ANNUAL REVIEW OF GENETICS, VOL 48 (2014)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact
Ulrike Bacher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Boveri at 100: cancer evolution, from preneoplasia to malignancy
Nicholas A. Wright
JOURNAL OF PATHOLOGY (2014)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis
M. R. Corces-Zimmerman et al.
LEUKEMIA (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
Raajit Rampal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The evolving genomic landscape of myeloproliferative neoplasms
Jyoti Nangalia et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)
FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
Naval Daver et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes
Raphael Itzykson et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2013)
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab et al.
BLOOD (2013)
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola et al.
BLOOD (2013)
Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications
Peter Valent et al.
CANCER RESEARCH (2013)
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis
Roberta Zanotti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase
G. Metzgeroth et al.
LEUKEMIA (2013)
A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
C. Marty et al.
LEUKEMIA (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: A role for the JAK2 V617F mutation re-evaluation
Donatella Colaizzo et al.
THROMBOSIS RESEARCH (2013)
Concise Review: Preleukemic Stem Cells: Molecular Biology and Clinical Implications of the Precursors to Leukemia Stem Cells
Ashley Pandolfi et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
Jelena D. Milosevic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Landscape of TET2 mutations in acute myeloid leukemia
S. Weissmann et al.
LEUKEMIA (2012)
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
Lambert Busque et al.
NATURE GENETICS (2012)
Clonal Architecture of Secondary Acute Myeloid Leukemia
Matthew J. Walter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
Max Jan et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Cancer stem cell definitions and terminology: the devil is in the details
Peter Valent et al.
NATURE REVIEWS CANCER (2012)
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima et al.
BLOOD (2011)
Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
P. Valent
CURRENT CANCER DRUG TARGETS (2011)
Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
V. Grossmann et al.
LEUKEMIA (2011)
Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias
Omar Abdel-Wahab et al.
CANCER RESEARCH (2010)
RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
Clara Ricci et al.
CLINICAL CANCER RESEARCH (2010)
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
J. Boultwood et al.
LEUKEMIA (2010)
RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
M-C Kuo et al.
LEUKEMIA (2009)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes
Veronique Gelsi-Boyer et al.
BMC CANCER (2008)
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia
Krzysztof Mrozek et al.
CURRENT OPINION IN ONCOLOGY (2008)
Unique effects of KIT D816V in BaF3 cells: Induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens
Matthias Mayerhofer et al.
JOURNAL OF IMMUNOLOGY (2008)
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
J. Gotlib et al.
LEUKEMIA (2008)
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science
O. Kilpivaara et al.
LEUKEMIA (2008)
Right on target: eradicating leukemic stem cells
Daniela S. Krause et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
V. De Stefano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
JAK2 (V617F) mutation in healthy individuals
Francesco Passamonti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis
D. Colaizzo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome
Raj K. Patel et al.
GASTROENTEROLOGY (2006)
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity
KJ Hope et al.
NATURE IMMUNOLOGY (2004)
Share Paper
